Smiro Qualitas

What Smiro Qualitas does

Smiro Qualitas Ltd is a UK-headquartered, founder-owned pharmaceutical consultancy founded in 2012 by Robert Smith, a Qualified Person (QP) with over 35 years of industry experience. The firm operates three core service lines — Clinical Services, Commercial Services, and Consulting Services — that together cover the end-to-end GMP/GDP compliance needs of pharmaceutical manufacturers, biotech and ATMP developers, and clinical trial sponsors operating in the UK and EU/EEA. Capabilities span licensed storage and distribution (15–25°C, 2–8°C, -80°C), clinical and commercial packaging/labelling, IMP and commercial batch certification/release, importation from Countries on a List and third-party countries, returns and destruction, comparator procurement, audits, PQS support and remediation, validation, regulatory authorisation support, and QP declarations.

The firm's underlying platform is a Pharmaceutical Quality System (PQS) implementation and remediation methodology, IRCA-certified GMP Pharmaceutical Quality Systems auditing capability, GAMP 5-aligned validation expertise, and Qualified Person batch certification and release processes executed under UK and EU legislation. The company operates from a ~1,400 sq ft GMDP-licensed facility in Haverhill, Suffolk, and a ~1,200 sq ft licensed EU facility in Paola, Malta, operated through wholly owned subsidiary Smiro Qualitas (EU) Ltd. Seven permanent professionals plus external QP consultants deliver bespoke engagements on long-term contracts or short-term assignments; pricing is quote-based and not publicly disclosed. In 2025, the firm carried out approximately seven audits, onboarded six new clients, was granted WDA and MIA licences in Malta, and was awarded Top Pharmaceutical Consultancy in Europe 2025 by Life Sciences Review Europe / AIM Healthcare and Pharmaceutical Awards 2026.

Name

Smiro Qualitas

Legal name

Smiro Qualitas Ltd

Website

https://smiroqualitas.co.uk

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Smiro Qualitas is a UK-founded pharmaceutical consultancy that delivers licensed GMP/GDP clinical, commercial, and consulting services — including QP batch certification and release, temperature-controlled storage, packaging/labelling, and PQS implementation — to pharma manufacturers, biotech, ATMP developers, and clinical trial sponsors across the UK and EU/EEA.

Ownership category

akta.pro rank

Product category

Pharmaceutical Consulting Services

NAICS

Other Scientific and Technical Consulting Services (54169), Professional, Scientific, and Technical Services (541)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYHLAGAOAE

Quality Assurance, GxP Compliance & Auditing FSP

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

• Pharmaceutical consulting
• GMP compliance audits
• Clinical trial supply
• Qualified person services
• Pharmaceutical quality systems

Headquarters

HQ city

Haverhill

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Others

Revenue model

1. Pharmaceutical Consulting Services: Strategic consulting solutions delivered on long-term contracts or short-term assignments: audits, pharmaceutical-based training (on-site and e-learning), PQS support and remediation, validation (including ultra-cold storage and cold-chain), MIA/MIA(IMP) and WDA(H) regulatory authorization support, QA consultancy, Authorisation to Ship and Importer of Records support, facility design support, and QP declarations and support.
2. Clinical Services: End-to-end clinical services including storage and distribution, batch reviews, QP certification and release (UK and EU), secondary packaging, in-house label design, just-in-time over-printing, extended expiry labelling, importation of clinical/named-patient/auxiliary supplies from Countries on a List and 3rd Countries, returns and destruction, and clinical trial packaging/labelling design.
3. Commercial Services: Commercial supply-chain services: RP/RPi support under WDA(H), importation of commercial products to whitelist and third-party countries, GMDP-certified storage and distribution with full temperature control, batch review, QP batch certification and release, secondary labelling and packaging, and supply chain management.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Smiro Qualitas is a privately held pharmaceutical consultancy that delivers clinical, commercial, and consulting services across the UK and EU. It provides licensed storage and distribution, QP batch certification and release, Pharmaceutical Quality System (PQS) implementation and remediation, validation, regulatory authorisation support, and Quality Assurance consulting under MHRA and Malta Medicines Authority licences from facilities in Haverhill (UK) and Paola (Malta).

Product overview

Smiro Qualitas operates a services portfolio (rather than a single software product) organised into three core service lines — Clinical Services, Commercial Services, and Consulting Services — all of which sit under a unified Quality Policy framework that governs manufacture, importation, storage, handling, distribution, certification, and release of medicinal products. Clinical Services provides end-to-end clinical trial support (storage, distribution, batch review, QP certification/release, labelling/packaging, importation of clinical, named-patient and auxiliary supplies, returns, destruction, comparator procurement); Commercial Services delivers RP/RP-i support, importation, GMDP-certified temperature-controlled storage and distribution, batch review, batch certification/release, secondary packaging, and supply chain management; and Consulting Services provides strategic support across audits, pharma-based training, PQS support and remediation, validation, MIA/MIA(IMP) and WDA(H) authorisation support, Quality Assurance consultancy, Authorisation to Ship / Importer of Records, facility design, and QP declarations. The three service lines are supported by Smiro Qualitas' licensed UK (Haverhill) and EU (Paola, Malta) facilities, which are authorised to manufacture and distribute in both the UK and Malta and to certify/release products across the UK and EU/EEA.

Differentiator

Problem solved

Functional benefit

Brands

• Smiro Qualitas (EU): EU division of Smiro Qualitas, operating from the Paola, Malta facility for EU pharmaceutical manufacturing, importation, wholesale distribution, batch certification and release.

Products and services

• Clinical Services End-to-end clinical services to keep pharmaceutical programmes running smoothly and compliantly in the UK and EU, including storage and distribution, batch review, QP certification and release, secondary packaging, in-house label design, just-in-time over-printing, extended expiry labelling, importation of clinical/named-patient/auxiliary supplies, returns and destruction, comparator procurement, and clinical trial packaging and labelling design.
• Commercial Services Commercial supply-chain services that simplify and streamline business operations, including RP/RP-i support under WDA(H), importation of commercial products into whitelist and third-party countries, GMDP-certified temperature-controlled storage and 24/7/365 distribution, in-depth batch review, QP batch certification and release in the EU and UK, secondary packaging and just-in-time over-printing, and end-to-end supply chain management.
• Consulting Services Strategic consulting offering delivering GMP/GDP audits, pharmaceutical-based training (on-site and e-learning), PQS support and remediation, validation including ultra-cold storage and cold-chain, MIA/MIA(IMP) and WDA(H) regulatory authorisation support, Quality Assurance consultancy, Authorisation to Ship and Importer of Records support, facility design support, and Qualified Person declarations and support.

Quantifiable outcome

• "Passed MHRA review during the first audit" after Smiro Qualitas implemented a QMS at a UK manufacturing facility with minimal resources, delivered on time.
• +2 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered flagship / strategic anchor for eu expansion and core / foundational — enables eu licensing.

• Malta Enterpriseflagship / strategic anchor for eu expansionStrategic or Co-development Partner · 1 November 2025Malta Enterprise (CEO George Gregory) publicly endorsed and supported Smiro Qualitas' establishment of its EU base in Paola, Malta. Spoke at the grand opening and stated: "We are pleased to support Smiro Qualitas in establishing their operations here and look forward to witnessing their continued success." Represents Malta's strategic backing for Smiro Qualitas' EU clinical-trials footprint.
• Malta Medicines Authoritycore / foundational — enables eu licensingOthers · 1 August 2025Regulatory authority that conducted the Feb 2025 inspection of the Paola (Malta) site and subsequently granted Smiro Qualitas (EU) Ltd the Wholesale Distribution Authorisation (WDA) and Manufacturing & Importation Authorisation (MIA) — required for clinical labelling, packaging, batch certification and release of imported commercial and clinical products in the EU.
• MHRA (Medicines and Healthcare products Regulatory Agency)Others · 1 August 2025

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Arriello: Pharmaceutical quality, regulatory, and compliance consultancy serving biotech and mid-size pharma. Comparable in QA/regulatory consulting focus and ATMP/biologics support.
• Maetrics: Specialist pharmaceutical and medical device quality, regulatory, and compliance consultancy offering GxP auditing, validation, and PQS remediation. Comparable in QA consulting scope and small/mid-biotech client base.
• ELC Group (now part of PharmaLex): Pharmaceutical regulatory affairs and compliance consultancy offering QA, CMC, and licensing support. Comparable in mid-market pharma regulatory/QA consulting focus and EU coverage.
• Concept Heidelberg: Germany-based provider of pharmaceutical training, GMP/GDP compliance consulting, and QP services. Directly comparable to Smiro Qualitas' consulting and pharma-training service line, particularly around GMP/GDP audits and QP declarations.
• PharmEng Technology: Pharmaceutical consulting firm providing GMP compliance, validation, and quality assurance services to pharma and biotech manufacturers. Directly comparable in GxP consulting and small/mid manufacturer client base.
• Voisin Consulting Life Sciences: European-headquartered regulatory and quality consulting firm supporting pharma, biotech, and ATMP developers with regulatory strategy, CMC, and QP services. Highly comparable in scope (regulatory, GxP compliance, ATMP) and customer base (small/mid pharma and biotech sponsors).
• NDA Group (now part of PharmaLex): Pharmaceutical regulatory and quality consulting firm offering regulatory affairs, pharmacovigilance, and QP services to pharma and biotech across Europe. Closely comparable in regulatory/QP consulting focus and European mid-market sponsor customer base.

Broad incumbents

• IQVIA: Worldwide clinical and commercial services provider with a sizeable regulatory and quality consulting practice. Overlaps with Smiro Qualitas on pharma quality/regulatory consulting and QP-adjacent services for large and mid-market sponsors.
• ICON plc: Global CRO offering clinical, regulatory, and laboratory services. Comparable in clinical trial and regulatory services for pharma, with substantially greater scale and geographic reach than Smiro Qualitas.
• Parexel International: Global CRO with extensive regulatory, clinical supply, and pharmacovigilance capabilities. Overlaps with Smiro Qualitas in clinical and regulatory services but at much greater scale and breadth; competes for mid-market sponsor work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/smiro-qualitas-ltd

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smiro Qualitas